Tag Archives: Moderna says more than 40pc of participants enrolled for COVID-19 vaccine trial

Drug developer Moderna Inc on Friday said it has so far enrolled 13,194 participants in the ongoing late-stage 30,000-volunteer U.S. trial testing its COVID-19 vaccine candidate. In a tweet, the company also said that 18% of the participants currently enrolled are Black, Latino, American Indian or Alaska Native, groups among the hardest hit by the coronavirus virus pandemic. Moderna began the …

Read More »